| Underrepresented populations in Parkinson's genetics research: current landscape and future directions AF Schumacher‐Schuh, A Bieger, O Okunoye, KY Mok, SY Lim, ... Movement Disorders 37 (8), 1593-1604, 2022 | 33 | 2022 |
| Mercury and Alzheimer’s disease: a look at the links and evidence J Azar, MH Yousef, HAN El-Fawal, A Abdelnaser Metabolic Brain Disease 36, 361-374, 2021 | 27 | 2021 |
| Gut brain axis: an insight into microbiota role in Parkinson’s disease SA Moustafa, S Mohamed, A Dawood, J Azar, E Elmorsy, NAM Rizk, ... Metabolic brain disease 36 (7), 1545-1557, 2021 | 15 | 2021 |
| Diversity in Parkinson’s disease genetics research: current landscape and future directions AF Schumacher-Schuh, A Bieger, O Okunoye, K Mok, SY Lim, S Bardien, ... medRxiv, 2021.12. 07.21266995, 2021 | 2 | 2021 |
| Precision health in Alzheimer disease: Risk assessment‐based strategies J Azar, M Salama, SB Chidambaram, B Al‐Balushi, MM Essa, ... Precision Medical Sciences 10 (2), 54-70, 2021 | 2 | 2021 |
| The State of Play of Parkinson's Disease in Africa: A Systematic Review and Point of View. OC Okunoye, YZ Zewde, J Azar, B Ayele, S Dindayal, A Moustafa, ... medRxiv, 2023.07. 07.23292392, 2023 | 1 | 2023 |
| Nutrigenomics in Parkinson’s Disease J Azar Nutrigenomics and the Brain, 109-119, 2022 | | 2022 |
| The Emerging Role of Vitamin D Deficiency as a Risk Factor of Parkinson’s Disease M El-Gamal, J Azar, R Hegazi Nutrigenomics and the Brain, 155-174, 2022 | | 2022 |
| A Preliminary Investigation of Neuroantibody Levels, Prevalence, and Environmental Factors in Patients with Neurological Dysfunction J Azar | | 2022 |
| Lack of diversity in Parkinson's disease genetic research: current landscape and future directions A Schumacher-Schuh, A Bieger, M Strelow, O Okunoye, K Mok, ... MOVEMENT DISORDERS 36, S321-S322, 2021 | | 2021 |
